Gentian

The availability of suitable substrata for larval recruitment can limit coral reef recovery and restrict reef development, as coral larvae require specific types of rocky settlement substrata Connell, 1973; Highsmith, 1982; Harrison and Wallace, 1990 ; . Recruitment of coral larvae is inhibited where substrata have become unstable Brown and Dunne, 1988; Lindahl, 1998; Fox et al., 1999 ; , overgrown by algae Birkeland, 1988; Wittenberg and Hunte, 1992; Gleason, 1999 ; , or covered with a fine layer of sand or silt Hodgson, 1990; Maida et al., 1994; Babcock and Mundy, 1996 ; . Even where the substratum is ideal for larval settlement, poor larval supply may sometimes limit coral reef recovery Lindahl, 1998; Nzali et al., 1998; Quinn and Kojis, 1999 ; . Coral Transplantation to Accelerate Natural Recovery Processes Transplanting coral fragments has been suggested as a means to rehabilitate reefs by bypassing the critical early stages of coral recruitment, especially on substrata not favorable to larval recruitment or to post-recruitment survival, Lindahl, 1998; Bowden-Kerby, 2001a ; . Coral fragments have a distinct advantage over newly settled larval recruits due to their considerably larger size, having increased survival and growth rates Sousa, 1984 ; , increased ability to compete for space Bothwell, 1981; Tunnicliffe, 1981 ; , and greater stability on unconsolidated substrata Gilmore and Hall, 1976; Highsmith, 1980; Lindahl, 1998 ; . Transplanted coral fragments would also potentially fare better than storm-generated ones, which sometimes have high mortality Bak and Criens, 1981; Knowlton et al., 1981 ; , presumably due to abrasion and tissue damage incurred during storm transport. Various transplantation methods have been attempted with the goal of restoring coral cover to reefs. Much of the restoration efforts to date have been focused on responding to acute episodes of damage; in particular the repair of reefs subsequent to ship groundings. Most of these efforts are located in high-energy reef front areas, using expensive methods, and requiring hundreds of hours underwater to secure dislodged coral colonies. Apparently little consideration has been given to the fact that the high-energy environments most often affected are normally dominated by stable sediment-free substrata where natural recruitment and recovery processes are most active, potentially making restoration efforts in these habitats unnecessary. The overall positive impact of expensive coral reef restoration projects has recently been questioned Harriott and Fisk, 1988b; Hatcher et al., 1989; Maragos, 1992; Edwards and Clark, 1998; Birkeland, 1999; Challenger, 1999 ; . Rather than abandoning the work, Maragos 1992 ; suggested that less costly methods should be developed. A recent reevaluation Edwards and Clark, 1998 ; , detailed the conditions where transplantation was most appropriate, and concluded that transplantation should be viewed as a tool of last resort, for use only where natural recruitment and recovery processes are failing. We concur with these sentiments. Simple, low-tech methods of coral transplantation have been investigated for restoring coral cover to damaged lower-energy reefs, using unattached coral fragments to mimic and accelerate asexual fragment-driven reef recovery processes Guzman, 1991, 1993; Lindahl, 1998; Fox et al., 1999; Bowden-Kerby, 1997, 2001a, b ; . Transplanting corals into lower energy areas precludes the necessity of securing coral transplants, considerably lowering cost and effort. A high survival rate for unattached coral transplants has been demonstrated for such sheltered areas Maragos, 1974; Harriot and Fisk, 1988a; Guzman, 1991, 1993; Lindahl, 1998; Bowden-Kerby 2001a, b ; , particularly for rubble environments and for larger fragment sizes.

In addition, the grasslands along road verges in the Natural Area are often more species-rich than much of the surrounding land with characteristic species such as red clover and bird'sfoot trefoil. Sometimes relatively uncommon plants present such as meadow crane's-bill, field scabious and black knapweed are present. Special species: Species-rich grasslands support good numbers of grassland invertebrates, especially butterflies and moths, which are dependant on this habitat as their food plants are often no longer commonly found in the wider countryside. Species of note include the small skipper, dingy skipper, Duke of Burgundy marbled white and cistus forester. Burnt-tip orchid and Autumn gentian occur in calcareous grasslands. Osunkwo, I. ; Cooney, E.; Bessmertny, O.; DiNatale, J.; Garvin, J.; Cairo, M.S. Children's Hospital of New York Presbyterian, Columbia University, New York; NY. Potential for this race to become an International Event and asked his friends Mr. Tetsuji Yuasa and Mr. Nobu Hachiki from the Japan ATV Association to solicit people to come to Guam to compete in the Smokin' Wheels Race; and.
One of the newer antipsychotic medications, because we reasoned that it might ameliorate some of the same problems in schizotaxic relatives that it does in schizophrenic patients. While the reasons for its effectiveness remain unclear, they probably do not include its antipsychotic properties, since the schizotaxic relatives were by definition ; not psychotic. As neurobiological mechanisms of schizotaxia become elucidated, treatments will likely include options that are broader and more specific than antipsychotic treatments alone. Some of these may be tested in the near future. For example, the demonstration that nicotine transiently normalizes impaired sensory gating in relatives implicates cholinergic neurotransmission in the normal mediation of the "filtering" function.69 Interestingly, we recently found that glucose, which also facilitates hippocampal cholinergic function see, for example, references 70 and 71 ; , improves long-term verbal memory in schizophrenic patients treated with clozapine.72 Whether glucose can also attenuate cognitive dysfunctions in schizotaxia remains to be tested, but it does illustrate the possibility that a broad range of nonanti-psychotic treatments with or without concomitant low doses of antipsychotic medications ; may be useful in treating schizotaxia. As the biological bases of schizotaxia become clearer, so will diagnostic criteria for the syndrome. This will allow the development of more targeted treatment strategies and homogeneous samples of research subjects. If successful treatments for schizotaxia can be demonstrated in adults, then the most important goal of schizotaxia research can be embarked upon, which is the prevention of schizophrenia. While we are certainly not at that point yet, we may be cautiously optimistic that the issue now is more related to when, rather than if, we will achieve that goal.

1. Davison S, Davis SR. New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 2003; 88: 2470 Howard BV, Hsia J, Ouyang P, Van Voorhees L, Lindsay J, Silverman A, et al. Postmenopausal hormone therapy is associated with atherosclerosis progression in women with abnormal glucose tolerance. Circulation 2004; 110: 201 Dudley EC, Hopper JL, Taffe J, Guthrie JR, Burger HG, Dennerstein L. Using longitudinal data to define the perimenopause by menstrual cycle characteristics. Climacteric 1998; 1: 18 Sormova I, Donat J. Risk factors of metabolic estrogen-deficiency syndrome in women after menopause and its relationship to hormone replacement therapy. Ceska Gynekol 2004; 69: 388 Cordero-MacIntyrez R, Lohman T, Rosen J, Peters W, Espana RC, Dickinson, et al. Weight loss is correlated with an improved lipoprotein profile in obese postmenopausal women. J Coll Nutr 2000; 19: 275 Amant C, Holm P, Xu Sh SH, Tritmant N, Kearney M, Losordo DW. Estrogen receptor-mediated, nitric oxide-dependent modulation of the immunologic barrier function of the endothelium regulation of Fas ligand expression by estradiol. Circulation 2001; 104: 2576 Wakatsuki A, Ikenoue N, Shinohara K, Watanabe K, Fukaya T. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women. Arterioscler Thromb Vasc Biol 2004; 24: 571 Ridker PM, Hennekens CH, Buring JE, Rifai N. C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836 Pradhan AD, Mansos JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002; 288: 980 Rifai N, Ridker PM. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem 2001; 47: 28 Rifai N, Ridker PM. Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. Clin Chem 2003; 49: 666 Ponthieux A, Herbeth B, Droesch S, Haddy H, Lambert D, Visvikis S. Biological determinants of serum sICAM-1, E-selectin, P-selectin and Lselectin levels in healthy subjects: the Stanislas study. Atherosclerosis 2004; 172: 299 Eschen O, Christensen JH, De Caterina R, Schmidt EB. Soluble adhesion molecules in healthy subjects. Nutr Metab Cardiovasc Dis 2004; 14: 180 Stauffer BL, Hoetzer GL, Smith DT, DeSouza CA. Plasma C-reactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy. J Appl Physiol 2004; 96: 143 Imhof A, Frohlich M, Loewel H, Helbecque N, Woodward M, Amouyel P, et al. Distribution of C-reactive protein measured by high-sensitivity assay in apparently healthy men and women from different populations in Europe. Clin Chem 2003; 49: 669 Meade TW, Dyer S, Howarth DJ, Imeson JD, Stirling Y. Antithrombin III and procoagulant activity: sex differences and effects of the menopause. Br J Haematol 1990; 74: 77 Sites CK, Toth MJ, Cushman M, L'Hommedieu GD, Tchernof A, Tracy RP. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 2002; 77: 128 Oger E, Alhene-Gelas M, Plu-Bureau G, Mennen L, Cambillau M, Guize L, et al. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy: time-dependent change in transdermal, but not oral estrogen users. Thromb Res 2001; 101: 35 DOI: 10.1373 clinchem.2005.052191 and ginger. 149; symptoms of a gentian overdose have not been reported!

The Ambiguity of Boundaries in the Fieldwork Experience: Establishing Rapport, and Negotiating Insider Outsider Status, " Sherif, 436. "Analyzing the Researcher's Work in generating data: The case of complaints, " Roulston et al., 856. "Angels of Vision: Enhancing Perception in Qualitative Research, " Peshkin, 238. "The Anthro Writes a Day, " Richardson, 254. " `Between Eye and Eye Stretches an Interminable Landscape': The Challenge of Philosophical Hermeneutics, " Freeman, 646. "Coming Clean at the Hypen: Ethics and Dialogue at a Local Community Center, " Dimitriadis, 578. "Describing the Bricolage: Conceptualizing a New Rigor in Qualitative Research, " Kincheloe, 679. "Detecting the Fictional Problem-Solvers in Time and Space: Metaphors Guiding Qualitative Analysis and Interpretation, " Moring, 346. "Do Whatever You Want": Audience s ; Created, Creating, Recreating, " Olesen, 267. "Educational Research and Intertextual Forms of Re ; Presentation: The Case for Dancing the Data, " Bagley and Cancienne, 221. "The Educational Researcher as Artist Working Within, " Slattery, 370. "Exhuming and Slaying Adorno, " Doane, 274 and gleevec. NURNBERG, B., SPICHER, K., HARHAMMER, R., BOSSERHOFF, A., Downloaded from jp.physoc by on March 14, 2008 FRANK, R., HILZ, H. & SCHULTZ, G 1994 ; . Purification of a novel G protein ocO-subunit firom mammalian brains. Biochemical Journal.
Patients with lymphoplasmocytic ders.Blood 27, 310 1966 ; . Anastasios and gliadel. 31. Ricke J., Klose K.J., Mignon M., Oberg K. & Wiedenmann B.: Standardisation of imaging in neuroendocrine tumours: results of a European delphi process. Eur J Radiol: 37 1 ; 8-17., Jahr: "2001"; 1, 084 Impact Punkte 32. Roznowski A.B. & Dignass A.: [Sustaining remission in Crohn disease with methotrexate--a placebo controlled study] Z Gastroenterol: 39 3 ; 265-7., Jahr: "2001"; 0, 803 Impact Punkte 33. Ruster B., Zeuzem S., Krump-Konvalinkova V., Berg T., Jonas S., Severin K. & Roth W.K.: Comparative sequence analysis of the core- and NS5-region of hepatitis Cvirus from tumor and adjacent non-tumor tissue. J Med Virol: 63 2 ; 128-34., Jahr: "2001"; 2, 881 Impact Punkte 34. Schmitt-Graff A., Nitschke R. & Wiedenmann B.: [Gastroenteropancreatic neuroendocrine endocrine tumors. Current pathologic-diagnostic view] Pathologe: 22 2 ; 105-13., Jahr: "2001"; 0, 472 Impact Punkte 35. Seehofer D., Rayes N., Naumann U., Neuhaus R., Muller A.R., Tullius S.G., Berg T., Steinmuller T., Bechstein W.O. & Neuhaus P.: Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation. Transplantation: 72 8 ; 1381-5., Jahr: "2001"; 4, 184 Impact Punkte 36. Seehofer D., Rayes N., Steinmuller T., Muller A.R., Settmacher U., Neuhaus R., Radke C., Berg T., Hopf U. & Neuhaus P.: Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation. Liver Transplantation: 7 11 ; 976-82., Jahr: "2001"; 3, Impact Punkte 37. Sturany S., Van Lint J., Muller F., Wilda M., Hameister H., Hocker M., Brey A., Gern U., Vandenheede J., Gress T., Adler G. & Seufferlein T.: Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of serine threonine kinases. J Biol Chem: 276 5 ; 3310-8., Jahr: "2001"; 7, 258 Impact Punkte 38. Tebbe J.J., Dietze T., Grote C. & Monnikes H.: Excitatory stimulation of neurons in the arcuate nucleus inhibits gastric acid secretion via vagal pathways in anesthetized rats. Brain Res: 913 1 ; 10-7., Jahr: "2001"; 2, 489 Impact Punkte 39. Teuber G., Berg T., Naumann U., Raedle J., Brinkmann S., Hopf U. & Zeuzem S.: Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C. J Viral Hepatitis: 8 4 ; 276-83., Jahr: "2001"; 2, 391 Impact Punkte 40. Teuber G., Lohr H.F., Kallinowski B., Berg T., Muller R. & Zeuzem S.: [Retrospective cohort study of lamivudine therapy in patients with chronic hepatitis B] Deut Med Wochenschr: 126 5 ; 97-102., Jahr: "2001"; 0, 704 Impact Punkte 41. Tillotson L.G., Lodestro C., Hocker M., Wiedenmann B., Newcomer C.E. & Reid L.M.: Isolation, maintenance, and characterization of human pancreatic islet tumor cells expressing vasoactive intestinal peptide. Pancreas: 22 1 ; 91-8., Jahr: "2001"; 1, 567 Impact Punkte 42. Tonnies H., Toliat M.R., Ramel C., Pape U.F., Neitzel H., Berger W. & Wiedenmann B.: Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation. Gut: 48 4 ; 536-41., Jahr: "2001"; 6, 17 Impact Punkte 43. von Marschall Z., Cramer T., Hocker M., Finkenzeller G., Wiedenmann B. & Rosewicz S.: Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma. Gut: 48 1 ; 87-96., Jahr: "2001"; 6, 17 Impact Punkte 44. Witt H., Luck W., Becker M., Bohmig M., Kage A., Truninger K., Ammann R.W., O'Reilly D., Kingsnorth A., Schulz H.U., Halangk W., Kielstein V., Knoefel W.T., Teich N. & Keim V.: Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronicpancreatitis. JAMA: 285 21 ; 2716-7., Jahr: "2001"; 17, 569 Impact Punkte 45. Zeeh J.M., Zorlu, Riley N.E., Hoffmann P., Ruwe M., Goebell H., Gerken G. & Dignass A.U.: Mycophenolate mofetil reduces tissue damage and inflammation in an experimental model of colitis in rats. Scand J Gastroentero: 36 1 ; 66-70., Jahr: "2001"; 1, 826 Impact Punkte.

Apotex v. The Minister of Health ofloxacin APO-OFLOX , December 17, 2003 Apotex sued the Minister in negligence, breach of statutory duty and discrimination because the Minister issued a Notice of Compliance NOC ; to Apotex eight months after a settlement between the patentee and Apotex. Judge affirms Order of Prothonotary, requiring disclosure of communications between officials of Health Canada and their legal advisors over which solicitor-client privilege is asserted if they intend to rely at trial on the fact of having sought legal advice to explain the delay in the issuance of the NOC. The Minister has appealed. Full Judgment 2003 FC 1480 and glucagon. CENTRAL PUERTO SOCIEDAD ANONIMA CHANGES IN ALLOWANCES FOR THE YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 English translation of financial statements originally issued in Spanish - See Note 18 to the Financial Statements ; stated in Argentine pesos ; Acquisition of Minority interest Under Argentine GAAP the acquisition of minority interest is accounted for using the pooling of interest method. Under the pooling of interest method at the time of the merger the assets and liabilities of the companies are combined at their historical book values. Under US GAAP the acquisition of some or all of the common stock held by a minority stockholder of a subsidiary is accounted for using the purchase method. Under the purchase accounting method the cost to an acquiring company should be determined using either the fair value of the consideration paid or the fair value of the assets acquired whichever is more evident. The excess of cost over the estimated fair value of the net assets acquired would result in goodwill and gentian.

Newton Elmo Renfro, known by most as "Moe, " passed away at Cedar Ridge Inn on Sunday, Jan. 18, 2004, at the age of 87. He was born Nov. 15, 1916, in Gustin, Texas, to Martin and May Renfro. Moe leaves behind his wife, Mavis Renfro of Aztec; daughter, Pat Luce of Wisconsin; son, Newton Renfro Jr. and his wife, Ann of Texas; daughter, Evelyn Votoupal and husband, Rudy of Illinois; stepson, Gary Reed and wife Robin of Missouri; stepson, Hank Schweinbold and wife Rhonda of Georgia; stepdaughter, Beverly Elder and husband Gene of Farmington; stepson, Mike Schweinbold and wife Carolyn of Missouri; stepdaughter, Patricia Wulfert and husband Richard of Farmington; stepdaughter, Peggy McKinney and husband Ron of Utah; stepson, Tony Schweinbold of California; stepdaughter, Rebecca Damron and husband Mark of Missouri; stepdaughter, Pamela Gleason and husband Mark of California; numerous grandchildren and great-grandchildren; two sisters, Marjorie Zimmerman and husband Lloyd of Missouri, and Ella Dean Swallows and husband Carl of Missouri. Moe was preceded in death by both his parents, three brothers and one sister. Military memorial services were held Jan. 22, at the VFW Post 614 in Aztec. Cremation was provided by the Alternative Society and glucosamine.
M : CAMMON et al. consisted of a minimal salts medium 1990a ; supplemented with 0.05% yeast extract that met the auxotrophicrequirements of the strains. Unless otherwise specified, carbon sources used were 2% glucose SSDex ; , 2% sucrose SSSuc ; , 3% glycerol SSGly ; , 1% potassium acetate SSAce ; , 1% potassium pyruvate SSPyr ; , 2% lactic acid SSLac ; , 2% ethanol SSEtoh ; or 0.1% oleic acid SSOle ; . The pH of these media were adjusted to 6.0 before sterilization. Agar 2%, Difco ; was added for plates. Escha'chia coli strain TGI supE hsdA5 thi A lac$roAB ; F' [traD36proAB + l a lacZAMI541 ; was commonly used for the propagation and amplification of plasmids. Frozen competent TG1 was prepared by a rubidium chloride procedure INES and UTERMOIII.EN 1994 ; . Miniprep plasmid DNA was prepared LEEand RASHEED 1990 ; and transformed into yeast and 1989 ; . by a lithium acetate procedure SCHIESTI. GIETZ Isolation of Acn- mutants. Parental strains MMYO11 and " Y O were typically cultured overnight at 30" in WGd, collected by centrifugati-on, and resuspended in water at a cell concentration of 10' ml. These samples were placed in a sonicating water bath for -30 sec to disperse small clumps of cells. The cell suspension was placed in a 150-mm petri dish and mutagenized with a Germicidal W lamp. Aliquots were taken in 15-20-sec intervals for plate counts and for stocks, which were kept at 4". Survival was quantitated by colony forming units on YPD plates. Cell samples in the 30-70% survival range were used further. Cells were usually allowed to grow overnight in several tubes of WG. These cultures were washed in semisynthetic salts no carbon source ; and incubated in 5 ml ofSSAce or SSOle at 30" until the cell number started to increase 4-6 hr ; . For mutant enrichment, cultures were treated with Nystatin in dimethylsulfoxide at a final concentration of 10 pg culture for 45-60 min at 30" LITTI.EM7001 ; 1975 survival on WD plates was between 0.2-2%. For mutant screening aliquots were diluted and plated onto YPG plates to eliminate respiratory deficient mutations in nuclear P I T ; mitochondrial petits ; genes from further analysis. After 3-4 days at SO", the colonies on YPG plates were replicated to SSAce and SSOle plates to screen for acetate- and oleate- phenotypes. Acetate- mutants were typically observed after 2-3 days of incubation at 30". while oleate- mutants were usually screened after 7 days. Screening for the inability to grow on oleate and acetate was an attempt to isolate a superset of peroxisomal assembly mutants simultaneously defective in both glyoxylate and 0-oxidation enzyme assembly and or function.Because of the existence of a previous set of oleate- PAS mutants ERDMANN al. 1989 ; , we el attempted to concentrate on the mutants that were unable to grow on acetate. All of the mutants were subjected to two more roundsof screening by streaking individual clones onto SSAce and SSOle plates. One hundred twenty-five mutants, -30% of the primary clones, were selected for further study. Complementation analysis: For most of the complementation analysis, MATa and MA% mutants were crossed on W D plates overnight before replica plating to W G , SSAce, and sometimes SSOle plates. After 2 - 3 days at 30, the acetate phenotype of the diploid was scored; if the diploids did not grow on SSAce plates, this was an indication that the haploids were members of the same complementation group. Each strain was usually tested against at least two alleles of a complementation group whenever possible, and members of a complementation group were tested among themselves several times. Some mutations were outcrossed into theopposite mating type to check for complementation groups within both mating types seebelow ; . In some instances strains were crossed on YPG plates or on semisynthetic plates containing 0.6% glucose; this latter condition was used to score the oleate phenotype reliably. Twenty-one strains were eliminated from further analysis, primarily due to their continuedgrowth after two successive replications onto SSAce plates. Physician Pharmacist Response rate 13% 65 of ~500 ; 10% 19 of ~200 ; Question 1: How often do you counsel on herbals? Never 7.5% 0% 1 time a month 10.4% 11.1% 1 time a week 20.9% 11.1% Weekly 44.8% 38.9% Daily 16.4% 38.9% Question 2: How do you feel about CAM? Don't believe it works 21.4% 8.7% Don't believe it is safe 24.3% 4.3% Is a good alternative to prescription medications 10.0% 26.1% Is a good add-on to prescription medications 40.0% 60.9% Don't care 4.3% 0% Question 3: How much interest do you have in CAM? No interest 10.6% 0% Some interest 71.2% 57.9% Very interested 18.2% 42.1% Question 4: How would you rate your knowledge of CAM? None 3.0% 0% Below average 30.3% 26.3% Average 42.4% 31.6% Above average 24.2% 26.3% Excellent 0% 15.8% Question 5: How have you seen the use of CAM change in the past year? Significant decrease 0% 0% Slight decrease 0% 5.3% No change 42.9% 15.8% Slight increase 46.0% 57.9% Significant increase 11.1% 21.1% Question 6: How helpful will this guide be as a counseling aide? Don't know 10.9% 5.3% Not helpful 0% 5.3% Somewhat helpful 45.3% 31.6% Very helpful 43.8% 57.9% Question 7: Check your location. Northern Utah Idaho 14.1% 16.7% Weber County North Davis County 10.9% 5.6% South Davis County Salt Lake County 57.8% 33.3% Utah County 6.3% 0% Central Utah Southern Utah 10.9% 44.4% Other 0% 0% Question 8: Check your type of practice pharmacy. Independent 73.7% Regional chain 15.8% National chain 0% Associated with a hospital or clinic 10.5% Family practice 30.8% Internal medicine 21.5% Specialty 47.7% Other 0% 0 and glycopyrrolate.